Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 26 4 2018
medline: 14 3 2020
entrez: 26 4 2018
Statut: ppublish

Résumé

Impaired metacognition is associated with difficulties in the daily functioning of people with psychosis. Metacognition can be divided into four domains: Self-Reflection, Understanding the Other's Mind, Decentration, and Mastery. This study investigated whether Metacognitive Reflection and Insight Therapy (MERIT) can be used to improve metacognition. This study is a randomized controlled trial. Patients in the active condition (n = 35) received forty MERIT sessions, the control group (n = 35) received treatment as usual. Multilevel intention-to-treat and completers analyses were performed for metacognition and secondary outcomes (psychotic symptomatology, cognitive insight, Theory of Mind, empathy, depression, self-stigma, quality of life, social functioning, and work readiness). Eighteen out of 35 participants finished treatment, half the drop-out stemmed from therapist attrition (N = 5) or before the first session (N = 4). Intention-to-treat analysis demonstrated that in both groups metacognition improved between pre- and post-measurements, with no significant differences between the groups. Patients who received MERIT continued to improve, while the control group returned to baseline, leading to significant differences at follow-up. Completers analysis (18/35) showed improvements on the Metacognition Assessment Scale (MAS-A) scales Self Reflectivity and metacognitive Mastery at follow-up. No effects were found on secondary outcomes. On average, participants in the MERIT group were, based on MAS-A scores, at follow-up more likely to recognize their thoughts as changeable rather than as facts. MERIT might be useful for patients whose self-reflection is too limited to benefit from other therapies. Given how no changes were found in secondary measures, further research is needed. Limitations and suggestions for future research are discussed.

Sections du résumé

BACKGROUND
Impaired metacognition is associated with difficulties in the daily functioning of people with psychosis. Metacognition can be divided into four domains: Self-Reflection, Understanding the Other's Mind, Decentration, and Mastery. This study investigated whether Metacognitive Reflection and Insight Therapy (MERIT) can be used to improve metacognition.
METHODS
This study is a randomized controlled trial. Patients in the active condition (n = 35) received forty MERIT sessions, the control group (n = 35) received treatment as usual. Multilevel intention-to-treat and completers analyses were performed for metacognition and secondary outcomes (psychotic symptomatology, cognitive insight, Theory of Mind, empathy, depression, self-stigma, quality of life, social functioning, and work readiness).
RESULTS
Eighteen out of 35 participants finished treatment, half the drop-out stemmed from therapist attrition (N = 5) or before the first session (N = 4). Intention-to-treat analysis demonstrated that in both groups metacognition improved between pre- and post-measurements, with no significant differences between the groups. Patients who received MERIT continued to improve, while the control group returned to baseline, leading to significant differences at follow-up. Completers analysis (18/35) showed improvements on the Metacognition Assessment Scale (MAS-A) scales Self Reflectivity and metacognitive Mastery at follow-up. No effects were found on secondary outcomes.
CONCLUSIONS
On average, participants in the MERIT group were, based on MAS-A scores, at follow-up more likely to recognize their thoughts as changeable rather than as facts. MERIT might be useful for patients whose self-reflection is too limited to benefit from other therapies. Given how no changes were found in secondary measures, further research is needed. Limitations and suggestions for future research are discussed.

Identifiants

pubmed: 29692285
pii: S0033291718000855
doi: 10.1017/S0033291718000855
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-313

Auteurs

S de Jong (S)

GGZ Noord-Drenthe,Department of Psychotic Disorders,Dennenweg 9, 9404 LA Assen,the Netherlands.

R J M van Donkersgoed (RJM)

Department of Clinical Psychology and Experimental Psychopathology,Faculty of Behavioral and Social Sciences,University of Groningen,Grote Kruisstraat 2/1, 9712 TS Groningen,the Netherlands.

M E Timmerman (ME)

Department of Clinical Psychology and Experimental Psychopathology,Faculty of Behavioral and Social Sciences,University of Groningen,Grote Kruisstraat 2/1, 9712 TS Groningen,the Netherlands.

M Aan Het Rot (M)

Department of Clinical Psychology and Experimental Psychopathology,Faculty of Behavioral and Social Sciences,University of Groningen,Grote Kruisstraat 2/1, 9712 TS Groningen,the Netherlands.

L Wunderink (L)

GGZ Friesland,PO Box 932 8901 BS Leeuwarden,the Netherlands.

J Arends (J)

GGZ Noord-Drenthe,Department of Psychotic Disorders,Dennenweg 9, 9404 LA Assen,the Netherlands.

M van Der Gaag (M)

Parnassia Psychiatric Institute,Zoutkeetsingel 40 2512 HN Den Haag,the Netherlands.

A Aleman (A)

Department of Clinical Psychology and Experimental Psychopathology,Faculty of Behavioral and Social Sciences,University of Groningen,Grote Kruisstraat 2/1, 9712 TS Groningen,the Netherlands.

P H Lysaker (PH)

Roudeboush VA Medical Center,1481 West 10th Street,Indianapolis, IN 46202,USA.

G H M Pijnenborg (GHM)

GGZ Noord-Drenthe,Department of Psychotic Disorders,Dennenweg 9, 9404 LA Assen,the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH